Du sach ma MADISON börst'n so?

Kosmonova buran

Datum Erster Hoch Tief Schluss     Stücke Volumen
  17.02.15     0,026     0,026§0,026 0,026 $ 400 10

GrB

NEW YORK (dpa-AFX) - Enttäuschenden Konjunkturdaten haben die US-Aktienindizes am Mittwoch wieder leicht ins Minus gedrückt. So fiel der Leitindex Dow Jones Industrial um 0,21 Prozent auf 18 009,66 Punkte, nachdem er am Dienstag noch Kurs auf seinen im Dezember erreichten Höchststand bei 18 103,45 Punkten genommen hatte. Der umfassendere S&P-500-Index verlor zur Wochenmitte ebenfalls 0,21 Prozent auf 2095,83 Punkte. Am Vortag hatte er noch bei 2101,30 Punkten ein Rekordhoch erreicht. An der Nasdaq gab der technologielastige Auswahlindex Nasdaq 100 (Nasdaq 100) zuletzt um 0,02 Prozent auf 4384,56 Punkte nach. Quelle: dpa-AFX

buran

http://www.ariva.de/madison_explorations-aktie GrB

EUROKURS ZIEHT LEICHT AN 18:06 19.02.15



Die Umlaufrendite börsennotierter Bundeswertpapiere verharrte bei 0,29 Prozent. Der Rentenindex Rex sank um 0,16 Prozent auf 140,09 Punkte. Der Bund-Future fiel um 0,04 Prozent auf 158,57 Punkte. Der Kurs des Euro stieg: Die Europäische Zentralbank (EZB) setzte den Referenzkurs auf 1,1387 (Mittwoch: 1,1372) Dollar fest. Der Dollar kostete damit 0,8782 (0,8794) Euro./edh/he Quelle: dpa-AFX

Datum Erster Hoch Tief Schluss     Stücke Volumen
  26.02.15     0,026    0,0268§0,026 0,026 $ 20.800 549

GrB

www.madisonexploration.com/

buran

finance.yahoo.com/q?s=MDEX&ql=1 GrB

Development Progress of Specific Cannabinoid Separation
Marketwired Madison Explorations, Inc.
October 8, 2014 8:00 AM finance.yahoo.com/news/...announces-development-120000701.html

.......--(Marketwired - Oct 8, 2014) - Madison Explorations, Inc., (MDEX) (the "Company") a leader in smokeless cannabinoid delivery technology, announces that the company has been able to separate specific cannabinoids and integrate them into the CannaStrips product. finance.yahoo.com/news/...announces-development-120000701.html

CannaStrips technology to deliver patient therapy of cannabinoids that are believed to have antioxidant properties unrelated to NMDA receptor antagonism can improve the effectiveness. There are a number of specific cannabinoids contained in marijuana, these cannabinoids have been found useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related disorders and inflammatory symptoms as well as cataracts, sleep disorders, seizures and autoimmune diseases. The cannabinoids are believed to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic invectives, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. The ability to separate the cannabinoids from the psychoactive THC will allow therapy free of the effects of THC, this is particularly advantageous in therapies involving children because they avoid toxicity that is encountered with therapies involving psychoactive high dose THC cannabinoids, specifically consisting of H, CH3, and COCH3. finance.yahoo.com/news/...announces-development-120000701.html

Brent Inzer commented: "The ability to deliver cannabinoid therapy specific to a patients exact needs greatly increases the possibility for monitoring the effectiveness of the therapy and hopefully promoting clinical trails and further in depth cannabinoid studies and testing." finance.yahoo.com/news/...announces-development-120000701.html

Madison Explorations, Inc.
(801) 326-0110
www.cannabinoidstrips.com
finance.yahoo.com/news/...announces-development-120000701.html

This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that Madison Explorations, Inc. expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in Madison Explorations, Inc.'s Quarterly and Annual Reports filed with the United States Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should any of Madison Explorations, Inc.'s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Madison Explorations, Inc.'s forward-looking statements. Except as required by law, Madison Explorations, Inc. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Madison Explorations, Inc. files from time to time with the SEC, including its Annual, Quarterly and Current Reports. finance.yahoo.com/news/...announces-development-120000701.html

The Company is a technology company positioned to become the leading smokeless cannabinoid technology provider, establishing a strong reputation for the highest quality, dosage reliability and formulation innovation. The Company is continuing its development and improvement of the products, production methods and formulations for its proprietary technology "CannaStrips" and is in advanced development of a number of additional smokeless delivery systems designed specifically for smokeless cannabinoid therapy. finance.yahoo.com/news/...announces-development-120000701.html

buran

::::::: 0,021 $ ,GrB

ROUNDUP/Aktien New York Schluss: Dow verliert nach Dollar-Plus und Ölpreis-Minus
21:25 19.03.15 http://www.ariva.de/news/...ch-Dollar-Plus-und-Oelpreis-Minus-5315621

Datum Erster Hoch Tief Schluss     Stücke Volumen
  24.04.15      0,20      0,20§0,20 0,20 $ 2.880 576

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  08.06.15      0,20      0,20§0,20 0,20 $ 130 26

GrB

Zeit       Kurs Stück
  15:30:05§0,16 $ 330
__________________
GRATULATION

:::::::::::::: 0,05 $ +25,00% +0,01 $
In Euro: 0,0463 € | Nasdaq OTC Other, 11.11.15 ,GrB

Zeit      Kurs Stück
  14:41:42§0,05 $ 3.000
__________________
GRATULATION

SK 0,05 $ SKP +0,00 Pott  +92,31% ,GrB

http://www.ariva.de/madison_explorat.-aktie/kurs GrB

...gab's früh ha ha bei die DR !!! COOL ...

SALT LAKE CITY, UTAH--(Marketwired - Sep 26, 2014) - Madison Explorations, Inc., (MDEX) (the "Company") a leader in smokeless cannabinoid delivery technology, announces that it's new CEO, Mr. Brent Inzer, today has issued a corporate update to the MDEX shareholders. finance.yahoo.com/news/...ons-inc-ceo-announces-113000560.html

CannaStrips are the result of lengthy research and development. CannaStrips are a safer and healthier alternative to smoking and has had an amazing reception throughout the medicinal cannabis community. We use only the finest medical cannabis leading to a smooth and consistent effect. cannabinoidstrips.com/